Search research articles
Contact Us
Filters
Showing results (131-140 of 182) with videos related to
Page
of 19
Sort By:
Journal of Asthma and Allergy
|
March 14, 2023
Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization
Jonathan Corren, David J Jackson, Thomas B Casale, et al.
The Lancet. Respiratory Medicine
|
November 29, 2025
Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial
David J Jackson, Njira L Lugogo, Mark Gurnell, et al.
Nature Medicine
|
May 2, 2017
Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation
Marie Toussaint, David J Jackson, Dawid Swieboda, et al.
Science Translational Medicine
|
October 3, 2014
Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation
Janine Beale, Annabelle Jayaraman, David J Jackson, et al.
Allergy
|
October 28, 2024
STING-dependent induction of neutrophilic asthma exacerbation in response to house dust mite
Yasmine Messaoud-Nacer, Elodie Culerier, Stéphanie Rose, et al.
The European Respiratory Journal
|
July 27, 2022
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study
Andrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
Immunotherapy
|
February 11, 2025
Benralizumab in severe eosinophilic asthma by biologic use and key clinical subgroups: real-world XALOC-1 programme: a plain language summary of publication
David J Jackson, Girolamo Pelaia, Benjamin Emmanuel, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 11, 2024
Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis
Alexandra M Nanzer, Anne-Catherine Maynard-Paquette, Vardah Alam, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 2, 2025
Exploring the Long-Term Utility of Remotely Monitored FeNO Suppression Testing in Severe Asthma
John Busby, Joshua Holmes, Mohammed Almutairi, et al.
Plos One
|
September 1, 2017
Rhinovirus induction of fractalkine (CX3CL1) in airway and peripheral blood mononuclear cells in asthma
Nadine Upton, David J Jackson, Alexandra A Nikonova, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 182) with videos related to
Sort By:
Page
of 19
Journal of Asthma and Allergy
|
March 14, 2023
Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization
Jonathan Corren, David J Jackson, Thomas B Casale, et al.
The Lancet. Respiratory Medicine
|
November 29, 2025
Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER): a multicentre, single-arm, phase 3b trial
David J Jackson, Njira L Lugogo, Mark Gurnell, et al.
Nature Medicine
|
May 2, 2017
Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation
Marie Toussaint, David J Jackson, Dawid Swieboda, et al.
Science Translational Medicine
|
October 3, 2014
Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation
Janine Beale, Annabelle Jayaraman, David J Jackson, et al.
Allergy
|
October 28, 2024
STING-dependent induction of neutrophilic asthma exacerbation in response to house dust mite
Yasmine Messaoud-Nacer, Elodie Culerier, Stéphanie Rose, et al.
The European Respiratory Journal
|
July 27, 2022
Adrenal function recovery after durable oral corticosteroid sparing with benralizumab in the PONENTE study
Andrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
Immunotherapy
|
February 11, 2025
Benralizumab in severe eosinophilic asthma by biologic use and key clinical subgroups: real-world XALOC-1 programme: a plain language summary of publication
David J Jackson, Girolamo Pelaia, Benjamin Emmanuel, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 11, 2024
Long-Term Effectiveness of Benralizumab in Eosinophilic Granulomatosis With Polyangiitis
Alexandra M Nanzer, Anne-Catherine Maynard-Paquette, Vardah Alam, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 2, 2025
Exploring the Long-Term Utility of Remotely Monitored FeNO Suppression Testing in Severe Asthma
John Busby, Joshua Holmes, Mohammed Almutairi, et al.
Plos One
|
September 1, 2017
Rhinovirus induction of fractalkine (CX3CL1) in airway and peripheral blood mononuclear cells in asthma
Nadine Upton, David J Jackson, Alexandra A Nikonova, et al.
Page
of 19